(Total Views: 396)
Posted On: 03/06/2021 11:30:00 AM
Post# of 155822
If you think it is semantics, that's fair. I think they have provided enough reason in the past to justify that feeling.
We will have to wait until Monday to know what the FDA has done for us or said. They certainly have requested more new patient data.
My initial post is more to state that timelines have been pushed back, but we are still in a good position for an approval, and it is worth going after. As demonstrated by large pharma companies continuing to pursue therapeutics.
Also, I do not think the word expedite means give CYDY an EUA in a matter of weeks or a month. I think it means they are working with CYDY to speed up the next steps, to me it seems they have.
We will have to wait until Monday to know what the FDA has done for us or said. They certainly have requested more new patient data.
My initial post is more to state that timelines have been pushed back, but we are still in a good position for an approval, and it is worth going after. As demonstrated by large pharma companies continuing to pursue therapeutics.
Also, I do not think the word expedite means give CYDY an EUA in a matter of weeks or a month. I think it means they are working with CYDY to speed up the next steps, to me it seems they have.
(1)
(0)
